BGNE


BeiGene’s Tislelizumab Gets Approval for First-Line Treatment of Advanced Non-Squamous NSCLC in China

China-based biopharmaceutical firm BeiGene (BGNE) has received approval for its anti-PD-1 antibody tislelizumab from the China National Medical Products Administration (NMPA) for the …

BeiGene’s BRUKINSA Receives Conditional Approval in China for Rare Lymphoma Treatment

Biotechnology company Beigene Ltd. (BGNE) has received conditional approval for BRUKINSA from the China National Medical Products Administration (NMPA) for treating Waldenström’s macroglobulinemia …

BeiGene Reports Phase 1b Data For Sitravatinib And Tislelizumab Combination

Commercial-stage biotechnology company BeiGene Ltd. reported data on the combination of tislelizumab and sitravatinib, which is being evaluated for the treatment of solid …

BeiGene, Assembly Bio Ink $540M China HBV Deal; Shares Surge In Pre-Market

BeiGene (BGNE) and Assembly Biosciences (ASMB) have announced a new collaboration in China for Assembly’s three clinical-stage core inhibitor candidates for the treatment of chronic …

Amgen Pours A Further $421M Into China’s BeiGene

Amgen (AMGN) has announced an additional investment of approximately $421 million in BeiGene’s (BGNE) registered direct offering of ordinary shares. This investment maintains Amgen’s current …

BeiGene Plans $2B Direct Offering; Analyst Sees Further Upside Ahead

Chinese biotech BeiGene (BGNE) has announced the pricing of a registered direct offering of 145,838,979 ordinary shares, par value $0.0001 per share to …

Chi-Med, BeiGene Join Forces For Solid Cancer Tumor Treatment

Hutchison China MediTech (HCM) and BeiGene (BGNE) have now entered into a clinical collaboration agreement for the treatment of various solid tumor cancers. …

Smarter Analysts’ Biotech Winners to Watch: Apollo Endosurgery Inc (APEN), Avadel Pharmaceuticals plc (AVDL), Beigene Ltd (ADR) (BGNE)

These stocks were recommended by Smarter Analyst’s newsletter BioPortfolio, a standout investment resource that allows each subscriber to see the newsletter’s whole history- …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts